Skip to main navigation Skip to search Skip to main content

Detection of α-Methylacyl-CoA Racemase in Serum and Urine Using a Highly Sensitive Electrochemical Immunodetector

  • Cleveland State University

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The detection of α-methylacyl-CoA racemase (AMACR), a novel biomarker for prostate cancer, is demonstrated in serum and urine using a novel immuno-detection method. The detection system consists of a three-electrode conventional electrochemical cell modified with a gating electrode for applying a gating voltage VG to the immune complex immobilized on the working electrode to provide signal amplification. The detection system is realized by integrating gating electrodes with screen-printed electrodes. This detection method does not require involved sample preparation procedures. The detection was demonstrated in serum and urine samples on the nanogram/mL level with VG equal to 0.6V. Detection in serum was also performed on the picogram/mL level with a limit of 100picogram/mL with VG=0.6V being a necessary condition. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Original languageEnglish
Pages (from-to)1441-1444
Number of pages4
JournalElectroanalysis
Volume26
Issue number7
DOIs
StatePublished - Jan 1 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarker detection
  • Immunoassay
  • Prostate cancer biomarker
  • Screen printed electrode

Cite this